Sunday, May 5, 2024 1:00 PM – 1:45 PM ET Exhibitor Workshop Room 1
Revolutionizing Multiplexing: Explore the Next Generation of Luminex Assays with Novel High-Plex and Dual Reporter Formats

Speaker
Stefan Jellbauer, Ph.D., Senior Manager, Product Management Immunoassays, Thermo Fisher Scientific
The COVID-19 pandemic, caused by SARS-CoV-2, put the terms “immune response” and “immunology” on everyone’s radar. There is an urgent need to understand the immune response and relevant immunological mechanisms underlying the progression and long-term effects of many diseases, including COVID-19. This workshop introduces advancements in multiplex analysis of RNA and protein using the Luminex® xMAP® technology. Leveraging Invitrogen™ ProcartaPlex™ and QuantiGene™ Plex assays overcomes limitations by allowing simultaneous screening of up to 80 biomarkers. These high-plex assays help save precious sample, time, and cost.
Thermo Fisher Scientific